iBio, Inc. (IBIO) Insider Trading Activity

NASDAQ$0.822
Market Cap
$52.96M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
298 of 849
Rank in Industry
168 of 491

IBIO Insider Trading Activity

IBIO Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$98,106
3
100
Sells
$0
0
0

Related Transactions

Duran FelipeChief Financial Officer
1
$50,132
0
$0
$50,132
Brenner MartinSee Remarks
1
$24,919
0
$0
$24,919
Banjak MarcChief Legal Officer
1
$23,055
0
$0
$23,055

About iBio, Inc.

iBio, Inc., a United States-based biotechnology firm, delivers contract development and manufacturing (CDMO) services to its collaborators and external clients. Its operations are structured into two distinct segments: Biopharmaceuticals and Bioprocessing. The company's leading therapeutic candidate, IBIO-100, is currently progressing through investigational new drug (IND) development, aimed at addressing systemic scleroderma and idiopathic pulmonary fibrosis. Additionally, iBio is engaged in the preclinical development of vaccine candidates, …

Insider Activity of iBio, Inc.

Over the last 12 months, insiders at iBio, Inc. have bought $98,106 and sold $0 worth of iBio, Inc. stock.

On average, over the past 5 years, insiders at iBio, Inc. have bought $376,550 and sold $49,838 worth of stock each year.

Highest buying activity among insiders over the last 12 months: Duran Felipe (Chief Financial Officer) — $50,132. Brenner Martin (See Remarks) — $24,919. Banjak Marc (Chief Legal Officer) — $23,055.

The last purchase of 13,934 shares for transaction amount of $23,055 was made by Banjak Marc (Chief Legal Officer) on 2026‑03‑26.

List of Insider Buy and Sell Transactions, iBio, Inc.

2026-03-26PurchaseBanjak MarcChief Legal Officer
13,934
0.0839%
$1.65
$23,055
-16.09%
2026-03-19PurchaseDuran FelipeChief Financial Officer
24,835
0.1512%
$2.02
$50,132
-30.00%
2026-03-19PurchaseBrenner MartinSee Remarks
12,336
0.0752%
$2.02
$24,919
-30.00%
2025-01-10PurchaseParada Antonio Bernardino Guimaraesdirector
183,823
2.1264%
$2.72
$499,999
-60.00%
2025-01-10PurchaseArkowitz Daviddirector
18,382
0.2126%
$2.72
$49,999
-60.00%
2025-01-10PurchaseBrenner MartinSee Remarks
9,191
0.1063%
$2.72
$25,000
-60.00%
2025-01-10PurchaseDuran FelipeChief Financial Officer
9,191
0.1063%
$2.72
$25,000
-60.00%
2025-01-10PurchaseBanjak MarcChief Legal Officer
9,191
0.1063%
$2.72
$25,000
-60.00%
2025-01-10PurchaseSender Garydirector
9,191
0.1063%
$2.72
$25,000
-60.00%
2025-01-10PurchaseClark William Ddirector
1,838
0.0213%
$2.72
$4,999
-60.00%
2023-11-01SaleBrenner MartinSee Remarks
4,881
0.0175%
$0.27
$1,296
-63.98%
2023-10-03SaleBrenner MartinSee Remarks
5,267
0.0187%
$0.30
$1,592
-67.58%
2023-10-02SaleBrenner MartinSee Remarks
4,215
0.0154%
$0.31
$1,311
-68.63%
2023-08-28SaleBrenner MartinSee Remarks
5,011
0.0211%
$0.31
$1,529
-68.36%
2023-07-27SaleBrenner MartinSee Remarks
4,515
0.0337%
$0.51
$2,308
-78.92%
2023-07-12SaleBrenner MartinSee Remarks
47,020
0.3517%
$0.59
$27,521
-81.02%
2023-06-21SaleBrenner MartinSee Remarks
4,184
0.0322%
$0.68
$2,849
-81.57%
2023-05-22SaleBrenner MartinSee Remarks
4,182
0.032%
$0.94
$3,910
-71.51%
2023-04-24SaleBrenner MartinSee Remarks
4,382
0.0338%
$1.20
$5,258
-75.42%
2023-03-23SaleBrenner MartinSee Remarks
5,213
0.0411%
$2.13
$11,112
-84.88%
Total: 83
*Gray background shows transactions not older than one year

Insider Historical Profitability

<0.0001%
Duran FelipeChief Financial Officer
35974
0.0559%
$29,624.5920
<0.0001%
Brenner MartinSee Remarks
30652
0.0477%
$25,241.92211
<0.0001%
Banjak MarcChief Legal Officer
25000
0.0389%
$20,587.5020
<0.0001%
Eastern Capital LTD10 percent owner
8629693
13.4195%
$7.11M66
DESANTIS CARL10 percent owner
5751143
8.9432%
$4.74M625
MCKEY JOHN D JRdirector
968284
1.5057%
$797,381.8726
Parada Antonio Bernardino Guimaraesdirector
183823
0.2859%
$151,378.2410
<0.0001%
Arkowitz Daviddirector
18382
0.0286%
$15,137.5810
<0.0001%
Sender Garydirector
9191
0.0143%
$7,568.7910
<0.0001%
Clark William Ddirector
1838
0.0029%
$1,513.5910
<0.0001%
DART KENNETH BRYAN10 percent owner
1
0%
$0.8210
*Gray background shows insiders who have made transactions during last year

Historical Insider Profitability vs. Competitors

$103,288,323
51
4.78%
$56.52M
$24,478,755
37
-34.59%
$53.59M
$115,646,156
35
16.45%
$54.05M
$47,296,259
27
18.16%
$44.4M
$390,510
22
17.68%
$58.22M

IBIO Institutional Investors: Active Positions

Increased Positions38+122.58%14M+406.13%
Decreased Positions11-35.48%2M-48.44%
New Positions26New12MNew
Sold Out Positions8Sold Out2MSold Out
Total Postitions58+87.1%16M+357.69%

IBIO Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Lynx1 Capital Management Lp$2,133.004.8%1.06M-482,676-31.37%2025-09-30
Ikarian Capital, Llc$1,247.002.81%617,327+17,414+2.9%2025-09-30
Ameriprise Financial Inc$974.002.19%482,300+482,300New2025-09-30
Opaleye Management Inc.$758.001.71%375,00000%2025-09-30
Vanguard Group Inc$554.001.25%274,070+130,209+90.51%2025-09-30
Boothbay Fund Management, Llc$357.000.8%176,862+17,414+10.92%2025-09-30
Geode Capital Management, Llc$306.000.69%151,309+39,008+34.73%2025-09-30
Citadel Advisors Llc$267.000.6%131,958+131,958New2025-09-30
Two Sigma Securities, Llc$91.000.21%45,079+16,517+57.83%2025-09-30
Susquehanna International Group, Llp$90.000.2%44,471+44,471New2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.